The hexavalent vaccine (DTaP-IPV-Hib-HepB vaccine) was developed by Sanofi Pasteur, the vaccines division of Sanofi. Once approved, the vaccine will be commercialized under two brands names: Hexyon in Western Europe and Hexacima in Eastern Europe. The vaccine will also be available in ...
Daptacel (DTaP, Sanofi Pasteur) and Ipol (IPV, Sanofi Pasteur). Study participants had been previouslySanofi Pasteur announced today that the FDA has approved Quadracel, a DTaP and inactivated poliovirus vaccine, for use among children aged 4 through 6 years....
Pentacel® & Quadracel® provide immunization against DTaP, IPV & Hib for your pediatric patients. Learn about continuity of antigens, immunization schedules & combination vaccines. Please see Important Safety Information and Prescribing Information.